Published Technical Documents
Standards, guidance and application literature from the bodies and manufacturers that publish it. Every entry links to the document page itself and quotes the sentence that says what it covers.
Standards, guidance and application literature from the bodies and manufacturers that publish it. Every entry links to the document page itself and quotes the sentence that says what it covers.
Roche Diagnostics
An overview of sequencing-by-expansion and the signal-to-noise problem it is meant to solve.
Source: diagnostics.roche.com · Retrieved 2026-10-30
What antibody tests could and could not tell us during the pandemic, written for a non-specialist reader.
Source: quidelortho.com · Retrieved 2026-10-30
QuidelOrtho
A chaptered reference on the infectious-disease assays used in donor screening.
Source: quidelortho.com · Retrieved 2026-10-30
How blood services can prepare for emerging infectious agents that reach the donor and the donation.
Source: quidelortho.com · Retrieved 2026-10-30
Evaluating a blood-bank mode used for quality testing of blood components on a haematology analyser.
Source: sysmex.co.jp · Retrieved 2026-10-30
Validation of a body-fluid mode on a urine particle analyser against a haematology analyser.
Source: sysmex.co.jp · Retrieved 2026-10-30
Basic evaluation of an automated nucleic-acid amplification detector for lymph-node metastasis.
Source: sysmex.co.jp · Retrieved 2026-10-30
A head-to-head performance comparison of a semi-automated urine chemistry analyser against prior models.
Source: sysmex.co.jp · Retrieved 2026-10-30
Cytiva
An ambient-stable whole-genome amplification kit, and what changed in its handling and consistency.
Source: cytivalifesciences.com · Retrieved 2026-10-05
Promega
The TB281 bulletin behind Promega’s luciferase assay system, on sensitivity and workflow.
Source: worldwide.promega.com · Retrieved 2026-10-05
Promega’s TM492 manual for a bioluminescent T-cell activation bioassay used in bioassay development.
Source: worldwide.promega.com · Retrieved 2026-10-05
Thermo Fisher Scientific
How variant mutations are tracked for diagnostic impact, using a point-of-care system as the case.
Source: thermofisher.com · Retrieved 2026-10-05
Every item here is a technical document its publisher made public: a standards-body scope page, a regulator guidance document, or a manufacturer application note or journal article. The entry links to that page and quotes the sentence describing what the document covers. It is not a record of work IVDmap has done.
Target audienceImplementation teams, labs, procurement managers
Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
2026-10-01
2026-10-09
professional use
Every document below is published by the body named on it, and this page links to that page. Nothing here is a record of work IVDmap has done.